NEW YORK (GenomeWeb) – Thermo Fisher Scientific said today that its board of directors has approved a new $1 billion share repurchase program.

Concurrently, the company also announced a $.15 per share quarterly dividend.

The repurchase authorization allows Thermo Fisher to buy $1 billion of its common stock in both the open market and through negotiated transactions, and replaces an existing authorization that had roughly $410 million remaining. Thermo Fisher said that it intends to begin repurchasing its stock in 2016. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.